---
$id: https://graph.org.ai/products/commodity/51111629
$type: Product
source: UNSPSC
code: "51111629"
title: "Clofarabine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clofarabine

**UNSPSC Code**: 51111629
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a ribonucleotide reductase inhibitor and purine antagonist with the molecular formula C10H11ClFN5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 762RDY0Y2H, chemically known as 9h-purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)- but generally known as clofarabine, which bears US NIH Compound Identifier 119182. European Medicines Agency schedules Clofarabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21902. The term CLOFARABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, No. 3, 2004, List 52). World Health Organization schedules clofarabine in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule clofarabine under HS 29349990 and SITC 51579. As of Q4 2014, CLOFARABINE remains the US FDA Preferred Term for this commodity. Clofarabine bears US NLM identifiers UMLS ID C0092777 and NCI Concept Code C26638. SMILES: C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)CL.

